Sara Kofman

Address:
1 Lilly Corporate Ctr
Indianapolis, IN 46285
United States
Telephone: 9714133910
Temporary address during session:
United States
Sara Kofman
Lobbying since: 2021
Senior Director, State Government Affairs

This lobbyist certified completion of required code of conduct training on 01/09/2023.

Monthly lobbying reports

Lobbyists are required to file monthly reports for any period in which they are employed, even if there is no reportable activity. The list below includes all reports for 2016 and later. Reports for periods prior to January 2016 are available in the historical archive.

Report for month Date filed/amended
August 2024 13/09/24 - 2:48 pm
July 2024 13/08/24 - 5:22 pm
June 2024 12/07/24 - 7:15 pm
March 2024 08/04/24 - 6:31 am
February 2024 14/03/24 - 12:00 pm
January 2024 14/02/24 - 10:37 am
December 2023 13/01/24 - 12:09 pm
November 2023 12/12/23 - 8:45 am
October 2023 14/11/23 - 11:10 am
September 2023 13/10/23 - 7:02 am
August 2023 12/09/23 - 7:01 am
July 2023 14/08/23 - 10:08 am
June 2023 12/07/23 - 5:47 am
May 2023 14/06/23 - 9:35 am
April 2023 12/05/23 - 8:23 am
March 2023 14/04/23 - 7:48 am
February 2023 15/03/23 - 9:47 am
January 2023 09/02/23 - 9:22 am
December 2022 12/01/23 - 3:57 am
November 2022 13/12/22 - 1:58 pm
October 2022 15/11/22 - 1:28 pm
September 2022 13/10/22 - 8:50 am
August 2022 13/09/22 - 12:13 pm
July 2022 11/08/22 - 8:37 am
June 2022 13/07/22 - 6:27 am
May 2022 13/06/22 - 7:18 am
April 2022 12/05/22 - 5:50 am
March 2022 29/03/22 - 6:45 am
February 2022 10/03/22 - 9:21 am
January 2022 08/02/22 - 9:55 am
December 2021 14/01/22 - 8:50 am
November 2021 07/12/21 - 8:03 am
October 2021 08/11/21 - 11:51 am
September 2021 11/10/21 - 11:19 am
August 2021 08/09/21 - 12:18 pm
July 2021 05/08/21 - 3:20 pm

Lobbyist employers

The list below includes all employers for 2016 and later. Employers for periods prior to January 2016 are available in the historical archive.

Employer Employment Registration Years Employed
BIOGEN View report 2022, 2023, 2024
ELI LILLY & COMPANY View report 2024
LEUKEMIA & LYMPHOMA SOCIETY View report 2021, 2022